NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
Back to search
Official data from USPTO
POWERING THE FUTURE OF MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
POWERING THE FUTURE OF MEDICINE
ST13
US500000098388319Class
1, 5, 40
Filing
98388319
Registration
7896282
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
08/19/2025
Trademark type
Word
Nice classes
1, 5, 40
Filing date
02/02/2024
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2021-06-00
First use in commerce
2021-06-00
Drawing code
4
Owner type
16
Owner location
Boca Raton, FL, US
Examiner
SINGH, DEEP K
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Akron BioProducts, LLC
Representatives
MICHAEL R. JUSTUS KATTEN MUCHIN ROSENMAN LLP
Technical classification
Nice Classes
Class 1Class 5Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparations and reagents for use in industry and science; biological preparations for use in cell cultures other than for medical or veterinary use; reagents for scientific and research use for chemical or biological analysis; plasmid DNA for use in the manufacture of viral vectorsmRNAother biologicsbiological preparations for use in industry and science; nucleases in the nature of cells for scientific and research purposes; cytokines in the nature of cells and biochemical reagents used in cell culture for scientific and research purposes; growth factors in the nature of cell growth mediagrowth media supplemental for growing cellsfor use in scientific research; cytokines and growth factors in the nature of cell culture media for growingconditioning or differentiating cells for use in the manufacture of pharmaceuticals
Class 5
Cytokines and growth factors in the nature of cell culture media for growingconditioning or differentiating cells for medical or veterinary preparationsspecifically in the form of cell or gene therapy productsgenetically engineered tissues or cells for medical transplant purposes; human plasma-derived supplementsblood plasma purified into proteins and converted into serums that are used in cell culture and formulation of cell and gene therapy products for medical purposes
Class 40
Manufacture of materials to the order and specification of others for the cell and gene therapy industry; manufacturing of plasmid DNAproteins and nucleasesgrowth media and bufferstransfection and transduction reagents to the order and specification of others
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/01/2025
PUBO
PUBLISHED FOR OPPOSITION
07/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/25/2025
EXPT
EXPARTE APPEAL TERMINATED
05/28/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
05/28/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/28/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
05/28/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/28/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/14/2025
GNRT
NON-FINAL ACTION E-MAILED
05/14/2025
CNRT
NON-FINAL ACTION WRITTEN
05/14/2025
EXPI
EX PARTE APPEAL-INSTITUTED
03/31/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
03/31/2025
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
03/31/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/24/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/30/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/30/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/30/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/30/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/30/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/02/2025
GNFR
FINAL REFUSAL E-MAILED
01/02/2025
CNFR
FINAL REFUSAL WRITTEN
01/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/22/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/28/2024
GNRT
NON-FINAL ACTION E-MAILED
08/28/2024
CNRT
NON-FINAL ACTION WRITTEN
08/28/2024
DOCK
ASSIGNED TO EXAMINER
08/27/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2024
NWAP
NEW APPLICATION ENTERED
02/06/2024
Continuous trademark protection
Get notified about every new filing that threatens POWERING THE FUTURE OF MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.